How Weight-Loss Jabs Are Reshaping Grocery and Dining Habits

Weight-loss medications like Wegovy and Mounjaro have experienced a massive surge in popularity over the last few years, with more than two million people in the UK now using them. While these drugs are primarily designed to help individuals manage their weight, recent research suggests they are also significantly reshaping consumer spending habits, particularly in the grocery and retail sectors.

According to a study published by market research company Worldpanel by Numerator, households with at least one member using a GLP-1 medication—which mimics the hormone that regulates hunger—spent an average of £418 less on groceries in the year after starting the treatment compared to non-user households. On a national scale, this change represents an estimated £780 million reduction in UK grocery sales.

This trend is mirrored in the United States. A peer-reviewed study from Cornell University found that US households with a member taking weight-loss drugs reduced their grocery spending by 5% within six months of starting the medication. This reduction rose to 8% among higher-income families.

The reduction in overall spending does not mean consumers are simply buying less of everything. Instead, their choices are shifting. "This isn't simply a story of shrinking demand. It's also a story of shifting demand," explained Nishita Pattni, a senior consultant at Worldpanel by Numerator.

Data shows that users are buying fewer calorie-dense, processed foods. The Cornell study noted a 10% decrease in spending on savoury snacks, alongside lower purchases of cheese, butter, soft drinks, and eggs. Similarly, UK users reported buying less chocolate and pastries, opting instead for fresh fruit and protein-rich foods like prawns and yoghurt.

Intriguingly, sales of certain personal care products have risen among users. Purchases of chewing gum, mouthwash, and hair dyes have increased, likely to counter common side effects of GLP-1 medications, such as bad breath and thinning hair.

The impact of these drugs extends beyond the supermarket shelves to the restaurant industry. Nearly two-thirds of UK users surveyed by Worldpanel reported cutting back on or trying to reduce the number of meals they eat out. Over half of the surveyed users described their eating habits as "mindful," meaning they eat in response to actual hunger cues rather than habit or routine.

This shift has also been observed in the US, where Cornell researchers recorded an 8% decline in spending at fast-food chains and coffee shops.

Despite the potential savings on food, the high cost of the medication remains a major concern for many. In the UK, the vast majority of patients must pay for their prescriptions privately, which can cost more than £300 a month. A survey conducted by the online medical service Zava found that cost was the primary reason patients stopped taking the drugs.

Furthermore, data from a private provider analyzed by the Health Foundation showed that more affluent areas of the UK have higher rates of weight-loss prescriptions on average, despite having a lower prevalence of obesity.

This financial barrier could have long-term health implications, especially since Cornell's research indicates that when people stop taking these medications, their grocery spending habits and food choices quickly revert to their pre-medication patterns.